1. | | Recruiting | Phase III Randomized Study of UT-15 in Patients with Primary Pulmonary Hypertension Condition: Pulmonary Hypertension |
2. | | Recruiting | A Study to Evaluate the Safety and Pilot Efficacy of Iloprost Inhaled Solution as Add-On Therapy with Bosentan in Subjects with Pulmonary Arterial Hypertension Conditions: Pulmonary Arterial Hypertension; PAH; Pulmonary Hypertension |
3. | | Recruiting | A Transition Study From Flolan® to Remodulin® in Patients with Pulmonary Arterial Hypertension Conditions: Pulmonary Arterial Hypertension; Pulmonary Hypertension |
4. | | Recruiting | Study of Inhaled Nitric Oxide for Preterm Infants Conditions: Respiratory Distress Syndrome; Infant, Premature; Sepsis; Pneumonia; Hypertension, Pulmonary |
5. | | Recruiting | Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II Condition: Pulmonary Hypertension |
6. | | Recruiting | ARIES - Ambrisentan in Patients with Moderate to Severe Pulmonary Arterial Hypertension (PAH) Condition: Pulmonary Hypertension |
7. | | Recruiting | Inhaled Nitric Oxide and Transfusion Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension Conditions: Sickle Cell Anemia; Pulmonary Hypertension |
8. | | Recruiting | Secondary Pulmonary Hypertension in Adults with Sickle Cell Anemia Conditions: Pulmonary Hypertension; Sickle Cell Anemia |
9. | | Recruiting | Secondary Prevention of Small Subcortical Strokes (SPS3) Trial Conditions: Cerebrovascular Accident; Hypertension |
10. | | Recruiting | Methods for Measuring Insulin Sensitivity Conditions: Obesity; Hypertension; Diabetes-Mellitus, Non-Insulin Dependent |
11. | | Recruiting | Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA) Condition: Hypertension |
12. | | Recruiting | Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension Condition: Hypertension |
13. | | Recruiting | Clevelox in the Postoperative Treatment of Hypertension Condition: Hypertension |
14. | | Recruiting | Clevelox in the Perioperative Treatment of Hypertension Condition: Hypertension |
15. | | Recruiting | Clevelox in the Preoperative Treatment of Hypertension Condition: Hypertension |
16. | | Recruiting | Study of Clevidipine Assessing its Postoperative Antihypertensive Effect in Cardiac Surgery Condition: Hypertension |
17. | | Recruiting | Study of Clevidipine Assessing its Preoperative Antihypertensive Effect in Cardiac Surgery Condition: Hypertension |
18. | | Not yet recruiting | Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients Conditions: Depression; Hypertension |
19. | | Recruiting | Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients Conditions: Open-Angle Glaucoma; Ocular Hypertension |
20. | | Recruiting | Phase 4 study comparing IOP lowering in OAG or OH in Caucasian or Japanese subjects C-02-32 Conditions: Open-Angle Glaucoma; Ocular Hypertension |
21. | | Recruiting | Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes Conditions: Open-Angle Glaucoma; Ocular Hypertension |
22. | | Recruiting | Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-70 Conditions: Open-Angle Glaucoma; Ocular Hypertension |
23. | | Recruiting | Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-02-41 Conditions: Open-Angle Glaucoma; Ocular Hypertension |
24. | | Recruiting | Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-69 Conditions: Open-Angle Glaucoma; Ocular Hypertension |
25. | | Recruiting | Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients with Glaucoma or Ocular Hypertension. Conditions: Glaucoma; Ocular Hypertension |
26. | | Recruiting | Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients with Glaucoma or Ocular Hypertension Conditions: Glaucoma; Ocular Hypertension |
27. | | Recruiting | Mechanism of Action of TRAVATAN 0.004% in Subjects with Glaucoma or Ocular Hypertension Conditions: Glaucoma; Ocular Hypertension |
28. | | Not yet recruiting | Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) Conditions: Atherosclerosis; Cardiovascular Diseases; Hypertension, Renovascular; Renal Artery Obstruction |
29. | | Recruiting | Genetic and Environmental Pathogenesis of PPH Conditions: Lung Diseases; Hypertension, Pulmonary |
30. | | Recruiting | The Effect of Tracleer™ on Male Fertility Condition: Hypertension, Pulmonary |
31. | | Recruiting | Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases Conditions: Pulmonary Hypertension; Lung Disease; Sickle Cell Disease; Cardiac transplant; Lung transplant |
32. | | Not yet recruiting | Impact of CPAP on Functional Outcomes in Milder Obstructive Sleep Apnea (CATNAP) Conditions: Lung Diseases; Sleep Apnea Syndromes; Sleep; Hypertension |
33. | | Recruiting | Improving Medication Adherence in Comorbid Conditions Conditions: Diabetes Mellitus, Type 2; Hypertension; Hyperlipidemia |
34. | | Recruiting | Hypertension in Hemodialysis Conditions: Hypertension; hemodialysis; Left Ventricular Hypertrophy |
35. | | Recruiting | ACE Inhibition and Novel Cardiovascular Risk Factors Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension |
36. | | Not yet recruiting | Macronutrients and Cardiovascular Risk Conditions: Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Hypertension |
37. | | Recruiting | Clinical Trial of Dietary Protein on Blood Pressure Conditions: Cardiovascular Diseases; Hypertension; Heart Diseases |
38. | | Not yet recruiting | Insulin Action: Role of Skeletal Muscle and Insulin-Mediated Blood Flow Condition: Hypertension |
39. | | Not yet recruiting | Dose-Response to Exercise in Women Aged 45-75 Years Conditions: Cardiovascular Diseases; Hypertension; Postmenopause |
40. | | Recruiting | Jackson Heart Study (JHS) Conditions: Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Disease; Hypertension; Cerebrovascular Disorders |
41. | | Recruiting | Safety and Efficacy of Xenical in Children and Adolescents with Obesity-Related Diseases Conditions: Diabetes Mellitus; Hypertension; Metabolic Disease; Obesity; Sleep Apnea Syndrome |
42. | | Recruiting | Metabolic Differences of Overweight Children and Children of Overweight Parents Conditions: Cardiovascular Disease; Hypertension; Non Insulin Dependent Diabetes Mellitus; Obesity |
43. | | Recruiting | Action to Control Cardiovascular Risk in Diabetes (ACCORD) Conditions: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus; ... |
44. | | Recruiting | A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
45. | | Recruiting | A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with chronic angle-closure glaucoma Conditions: Glaucoma, Angle-Closure; Ocular Hypertension |
46. | | Recruiting | A long-term safety study of once-daily Travatan Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
47. | | Recruiting | A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT) Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
48. | | Recruiting | A safety and efficacy study of Travoprost 0.004% compared to Latanoprost 0.005% in patients with open-angle glaucoma(OAG) or ocular hypertension(OHT) Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
49. | | Recruiting | The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study Conditions: Pseudotumor Cerebri; Cystinosis |
50. | | Recruiting | Establishing the Physiology of Syringomyelia Conditions: Arnold Chiari Deformity; Hydrocephalus; Syringomyelia |